Manfred Stapff's Breakthrough Book Hits #1 on Amazon, Tackles Misinformation with Real-World Evidence
Newsfile· 2025-06-05 18:00
Manfred Stapff's Breakthrough Book Hits #1 on Amazon, Tackles Misinformation with Real-World EvidenceJune 05, 2025 2:00 PM EDT | Source: Avazona Ltd.Summary: Dr. Manfred Stapff's newly released book, Real-World Evidence Unveiled: Navigating the Maze of Modern Misinformation, has soared to #1 on Amazon in multiple categories. New York, New York--(Newsfile Corp. - June 5, 2025) - Candid-Advisory founder and renowned physician-scientist Dr. Manfred Stapff has made a notable impact in the publishi ...
BetterInvesting™ Magazine Update on The Walt Disney Co. (NYSE: DIS)
Prnewswire· 2025-06-05 17:58
TROY, Mich., June 5, 2025 /PRNewswire/ -- Based on recent updated information, the Securities Review Committee of BetterInvesting Magazine has revised its previous decision pertaining to Stride Inc.'s announced selection as the "Stock to Study" for the August 2025 issue. The Walt Disney has been chosen instead as the "Stock to Study" for August.The Walt Disney Co.'s recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Secu ...
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Benzinga· 2025-06-05 17:56
Alvotech ALVO on Thursday collaborated with Dr. Reddy's Laboratories Ltd. RDY to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets.Merck & Co Inc's MRK Keytruda (pembrolizumab) is indicated for numerous cancer types.Keytruda's worldwide sales were $29.5 billion in 2024. The collaboration combines Dr. Reddy's and Alvotech's capabilities in biosimilars, speeding up the development process and extending the global reach for this biosimilar candidate ...
Tesla shares continue to plunge on Musk's political clash, global sales slump
Proactiveinvestors NA· 2025-06-05 17:56
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success
ZACKS· 2025-06-05 17:56
Key Takeaways LYRA shares jumped 355.5% this week after LYR-210 met the goal in the phase III ENLIGHTEN 2 CRS study. LYR-210 showed strong symptom relief and improved SNOT-22 scores at 24 weeks, starting as early as week 4. Lyra plans to discuss ENLIGHTEN 2 data with the FDA and may seek approval for LYR-210 in CRS without polyps.Shares of Lyra Therapeutics (LYRA) have skyrocketed 355.5% in a week after the company announced encouraging results from the late-stage study on its lead candidate, LYR-210, whi ...
Why PVH Stock Tumbled Today
The Motley Fool· 2025-06-05 17:55
Shares of PVH (PVH -17.23%), the diversified apparel company and parent of brands like Calvin Klein and Tommy Hilfiger, were falling today after it reported solid results in its first-quarter earnings report, but cut its outlook for the full year.As of 12:37 p.m., the stock was down 17.7%. What's ailing PVH?With uncertainty around tariffs and the broader economy, apparel companies have faced a challenging environment, and PVH is no different.Revenue rose 2% to $1.98 billion, ahead of its guidance calling fo ...
Meta Tests 3D Instagram Photos, Virtual Desktop for AR/VR Headsets
PYMNTS.com· 2025-06-05 17:55
As Apple’s Vision Pro reportedly faces slowing demand, Meta is leaning into its existing social ecosystem and AI tools to make everyday digital content more immersive and accessible.The update is part of Meta’s broader push into spatial computing, including a new Navigator virtual desktop, which brings PC-like multitasking to Quest.Meta is testing AI-generated 3D Instagram photos on Quest headsets, transforming standard 2D images into immersive spatial experiences without requiring 3D cameras.Meta is steppi ...
Super Group: A Lot Of Potential Outside Of The U.S., But Can It Execute?
Seeking Alpha· 2025-06-05 17:53
Super Group (SGHC) Limited (NYSE: SGHC ) recently reported its Q1 ’25 results , which were record-breaking for Q1, but the guidance didn’t impress investors, signaling some weakness ahead. I wanted to go through the numbers and give some commentsMSc in Finance. Long-term horizon investor mostly with 5-10 year horizon. I like to keep investing simple. I believe a portfolio should consist of a mix of growth, value, and dividend-paying stocks but usually end up looking for value more than anything. I also sell ...
XIAOMI(1810.HK):KEY TAKEAWAYS FROM XIAOMI INVESTOR DAY 2025
Ge Long Hui· 2025-06-05 17:53
SU7's outstanding sales performance with 76k unit delivery in 1Q25, and maintained delivery target of 350k units in 2025. In addition, mgmt. expected to invest RMB 3.5bn into R&D for smart EV biz, focusing on autonomous driving technologies such as full-domain end-to-end model, LiDAR plus 4D mm-wave radar with 700T computing power, and self-developed chips (next-gen NPU optimized). As for profitability timeline, mgmt. is pleased about the narrowing operating losses and expected smart EV business to turn pro ...
Procter & Gamble slashing up to 7,000 jobs amid restructuring effort
Fox Business· 2025-06-05 17:51
Procter & Gamble on Thursday said that it will cut up to 7,000 jobs, or 15% of its non-manufacturing workforce, over the next two years as part of a broader restructuring effort. "As always, employee separations will be managed with support and respect, and in line with our principles and values and local laws," P&G said. "Specific impacts by region or site are not available at this time." The two-year restructuring plan comes as consumer goods giants P&G and Unilever brace for muted demand in 2025, stemmin ...